Trials / Completed
CompletedNCT03606629
SOLARIS Endoprosthesis in Iliac Occlusive Disease
Solaris Endoprosthesis Performance in Treatment of Patients With Peripheral Occlusive Arterial Disease in the Iliac Territory - Post-Marketing Solaris I Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Scitech Produtos Medicos SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Fifty patients will be treated with Solaris Endoprosthesis and followed up to 2 years with Walking Impairment Questionnaire and Doppler Ultrasound evaluation in 30 days, 6 months and 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endoprosthesis implantation | Endoprosthesis implantation by Percutaneous Angioplasty |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2021-04-30
- Completion
- 2022-04-30
- First posted
- 2018-07-31
- Last updated
- 2022-05-10
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03606629. Inclusion in this directory is not an endorsement.